Metharbital was patented in 1905 by Emil Fischer working for Merck. It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant used in the treatment of epilepsy. It has similar properties to phenobarbital.
This page contains content from the copyrighted Wikipedia article "Metharbital"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
